True statement regarding methadone are all EXCEPT
**Question:** True statement regarding methadone are all EXCEPT
A. Methadone is a strong analgesic and an opioid receptor agonist.
B. Methadone is rapidly absorbed and has a short half-life.
C. Methadone is typically used as a maintenance drug for opioid addiction.
D. Methadone does not cross the blood-brain barrier.
**Correct Answer:** D. Methadone does not cross the blood-brain barrier.
**Core Concept:** Methadone is a synthetic opioid analgesic with a wide range of pharmacological properties. It is a potent agonist at mu-opioid receptors, which explains its strong analgesic effect. Methadone has a long half-life, allowing for once-daily dosing and making it useful for pain management and in the treatment of opioid addiction.
**Why the Correct Answer is Right:** Methadone does cross the blood-brain barrier, as it is a lipophilic molecule. However, the misconception lies in the assumption that methadone does not cross the blood-brain barrier at all. In reality, it does cross the barrier, but its concentration in the brain is significantly lower than that of other opioids due to its lipophilicity, which causes methadone to preferentially distribute into fatty tissues rather than the brain.
**Why Each Wrong Option is Incorrect:**
A. Methadone is a strong analgesic and an opioid receptor agonist: As mentioned earlier, methadone is indeed a potent agonist at mu-opioid receptors, which explains its analgesic effect.
B. Methadone has a short half-life: Contrary to the statement, methadone has a relatively long half-life (typically around 24-50 hours), allowing for once-daily dosing and making it useful for pain management and addiction treatment.
C. Methadone is typically used as a maintenance drug for opioid addiction: This statement is accurate, as methadone is commonly used in maintenance therapy for opioid addiction, helping to reduce cravings and withdrawal symptoms while allowing the patient to function normally in society.
**Clinical Pearl:** It is essential to understand that methadone's long half-life and lipophilicity lead to a slow distribution and elimination from the body, which is crucial for its therapeutic use in pain management and addiction treatment. The misconception about methadone not crossing the blood-brain barrier is a common misconception, but methadone does cross the barrier, though its concentration in the brain is lower than that of other opioid drugs due to its lipophilicity.